Perspective Therapeutics, Inc. (CATX)
2.27
-0.25
(-9.92%)
USD |
NYAM |
Oct 13, 16:00
2.33
+0.06
(+2.64%)
After-Hours: 04:27
Perspective Therapeutics Total Return Price : 2.27 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 2.27 |
| October 12, 2026 | 2.52 |
| October 09, 2026 | 2.66 |
| October 08, 2026 | 2.71 |
| October 07, 2026 | 2.46 |
| October 06, 2026 | 2.36 |
| October 05, 2026 | 2.57 |
| October 02, 2026 | 2.76 |
| October 01, 2026 | 2.72 |
| September 30, 2026 | 2.75 |
| September 29, 2026 | 2.62 |
| September 28, 2026 | 2.50 |
| September 25, 2026 | 2.52 |
| September 24, 2026 | 2.50 |
| September 23, 2026 | 2.62 |
| September 22, 2026 | 2.96 |
| September 21, 2026 | 2.97 |
| September 18, 2026 | 2.88 |
| September 17, 2026 | 2.88 |
| September 16, 2026 | 2.70 |
| September 15, 2026 | 2.73 |
| September 14, 2026 | 2.92 |
| September 11, 2026 | 2.81 |
| September 10, 2026 | 2.77 |
| September 09, 2026 | 2.99 |
| Date | Value |
|---|---|
| September 08, 2026 | 3.12 |
| September 04, 2026 | 3.13 |
| September 03, 2026 | 3.12 |
| September 02, 2026 | 3.10 |
| September 01, 2026 | 3.10 |
| August 31, 2026 | 3.16 |
| August 28, 2026 | 3.11 |
| August 27, 2026 | 3.18 |
| August 26, 2026 | 3.16 |
| August 25, 2026 | 3.29 |
| August 24, 2026 | 3.19 |
| August 21, 2026 | 3.30 |
| August 20, 2026 | 3.21 |
| August 19, 2026 | 3.48 |
| August 18, 2026 | 3.21 |
| August 17, 2026 | 3.22 |
| August 14, 2026 | 3.20 |
| August 13, 2026 | 3.10 |
| August 12, 2026 | 3.26 |
| August 11, 2026 | 3.18 |
| August 10, 2026 | 3.00 |
| August 07, 2026 | 3.00 |
| August 06, 2026 | 2.97 |
| August 05, 2026 | 2.94 |
| August 04, 2026 | 3.00 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Anika Therapeutics, Inc. | 20.53 |
| MiMedx Group, Inc. | 4.69 |
| ABVC BioPharma, Inc. | 0.979 |
| Enovis Corp. | 18.99 |
| Edwards Lifesciences Corp. | 85.27 |